News

Prof. Eva Martínez-Cáceres, MD, from IGTP, gave an invited talk entitled ‘Immunotherapy with autologous tolerogenic dendritic cells for treatment of autoimmune diseases’ at Immunodays (Madrid) 2024.

Prof. Eva Martínez-Cáceres, MD from IGTP was invited to the 22nd Annual Conference Laboratory Medicine. Egyptian Society of Laboratory Medicine (Egypt). The talk presented online was entitled ‘Immunotherapy with autologous tolerogenic dendritic cells for treatment of autoimmune diseases’.

SAVE THE DATE! IMMUTOL 1st Annual Meeting will be held on 6th and 7th June 2024 in Barcelona at IQS facilities.

Press Release: English https://techtransfer.iqs.edu/en/news/new-effective-therapies-for-multiple-sclerosis/ Spanish https://techtransfer.iqs.edu/actualidad/nuevas-terapias-efectivas-para-la-esclerosis-multiple/ Catalan https://techtransfer.iqs.edu/ca/actualitat/noves-terapies-efectives-per-lesclerosi-multiple/

The IMMUTOL Consortium, led by Silvia Gregori (San Raffaele Telethon Institute for Gene Therapy– SR-TIGET) successfully kicked-off the project at a hybrid event, held at the Fondazione Telethon, Milano (Italy), between 24th and 25th of May. Thanks to EU Horizon Europe (Grant Agreement Nr.: 101080562) for supporting fast-tracking the development and validation of an Advanced…